PMID- 35503774 OWN - NLM STAT- MEDLINE DCOM- 20230918 LR - 20230919 IS - 1545-1550 (Electronic) IS - 1526-6028 (Linking) VI - 30 IP - 5 DP - 2023 Oct TI - Clinical Outcomes of Additional Below-The-Ankle Intervention Compared to Below-The-Knee Intervention Alone: A Post-Hoc Analysis of a Prospective Multicenter Study. PG - 711-720 LID - 10.1177/15266028221092981 [doi] AB - PURPOSE: To investigate the clinical implication of additional below-the-ankle (BTA) intervention in patients with chronic limb-threatening ischemia (CLTI) undergoing below-the-knee (BTK) intervention. MATERIALS AND METHODS: A sub-analysis was performed using data from the LIBERTY trial (ClinicalTrials.gov identifier NCT01855412), a prospective, observational, core-laboratory adjudicated, multicenter study of endovascular intervention in 1204 patients. Patients with CLTI (Rutherford Classification 4-6) who underwent BTK intervention were included in this sub-analysis. Participants were then stratified into 2 treatment groups according to whether at least one lesion intervened on was BTA (n=66) or not (n=273). The decision on whether and where to intervene was made during the procedure. The main outcome measures included major amputation, target vessel revascularization (TVR), major adverse events (MAE), survival, amputation-free survival, major adverse limb events or peri-operative death (MALE-POD), and all-cause death. Other outcome measures included procedural success, procedural complications, and wound healing rate. RESULTS: There were no differences in procedural success or severe angiographic complications between the 2 groups. At 1-year post-procedure, patients in the BTK group had a higher rate of freedom from major amputation (95.0% vs. 86.9%, respectively; HR: 2.87, 95% CI: 1.17-7.03), a higher rate of freedom from TVR (80.1% vs. 66.9%, respectively; HR: 1.94, 95% CI: 1.14-3.32), a higher rate of freedom from MALE-POD (94.6% vs. 86.9%, respectively; HR: 2.65, 95% CI: 1.10-6.41), and a higher rate of freedom from MAE at both 1 (76.0% vs. 60.1%, respectively; HR: 2.00, 95% CI: 1.24-3.22) and 3 years post procedure (67.5% vs. 55.8%, respectively; HR: 1.69, 95% CI: 1.08-2.65). There was a significantly lower rate of survival in the BTK group at 3 years (74.3% vs. 91.1%, respectively; HR: 0.35, 95% CI: 0.14-0.87). After risk adjustment, there was a higher rate of all-cause death in the BTK group at 3 years (19.4% vs. 9.1%, respectively; p=0.023) post-intervention. CONCLUSION: Patients with disease requiring intervention to BTA lesions have a potential increased amputation rate in the short term, but BTA intervention carries a potential survival benefit in the long term when compared to BTK intervention alone. FAU - Metser, Gil AU - Metser G AUID- ORCID: 0000-0001-7816-7722 AD - Division of General Internal Medicine, Department of Medicine, Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, USA. FAU - Puma, Joseph AU - Puma J AD - Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. FAU - Mustapha, Jihad AU - Mustapha J AD - Advanced Cardiac and Vascular Centers, Grand Rapids, MI, USA. FAU - Adams, George L AU - Adams GL AUID- ORCID: 0000-0002-9820-943X AD - UNC Rex Healthcare, Raleigh, NC, USA. FAU - Ratcliffe, Justin AU - Ratcliffe J AD - Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. FAU - Khullar, Pankaj AU - Khullar P AD - Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. FAU - Rosero, Joshua H C AU - Rosero JHC AD - Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. AD - Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA. FAU - Armstrong, Ehrin J AU - Armstrong EJ AD - Adventist Heart and Vascular Institute, Adventist Health St. Helena, St. Helena, CA, USA. FAU - Zayed, Mohamed AU - Zayed M AD - Department of Surgery, Section of Vascular Surgery, Washington University School of Medicine, St. Louis, MO, USA. FAU - Green, Philip AU - Green P AD - Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. LA - eng SI - ClinicalTrials.gov/NCT01855412 PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20220503 PL - United States TA - J Endovasc Ther JT - Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists JID - 100896915 SB - IM MH - Humans MH - *Ankle MH - Prospective Studies MH - Treatment Outcome MH - *Lower Extremity/blood supply MH - Wound Healing OTO - NOTNLM OT - below-the-ankle intervention OT - critical limb threatening ischemia OT - endovascular therapy OT - major amputation OT - pedal artery disease OT - peripheral artery disease EDAT- 2022/05/04 06:00 MHDA- 2023/09/18 12:43 CRDT- 2022/05/03 13:33 PHST- 2023/09/18 12:43 [medline] PHST- 2022/05/04 06:00 [pubmed] PHST- 2022/05/03 13:33 [entrez] AID - 10.1177/15266028221092981 [doi] PST - ppublish SO - J Endovasc Ther. 2023 Oct;30(5):711-720. doi: 10.1177/15266028221092981. Epub 2022 May 3.